open access

Vol 21, No 5 (2016)
Original research articles
Published online: 2016-09-01
Submitted: 2016-01-08
Get Citation

Validation and clinical implementation of commercial secondary check software with heterogeneity corrections

Vijayalakshmi Kuppusamy, Vivekanandan Nagarajan, Lavanya Murugan
DOI: 10.1016/j.rpor.2016.06.003
·
Rep Pract Oncol Radiother 2016;21(5):473-479.

open access

Vol 21, No 5 (2016)
Original research articles
Published online: 2016-09-01
Submitted: 2016-01-08

Abstract

Aim

To validate and implement PTW diamond secondary check software (SCS) in a routine clinical use.

Background

The secondary independent monitor unit or dose calculation verifications have led to a significant increase in the workflow associated with QA treatments. Modelling, validation and commissioning are necessary steps thereby making it a useful tool for QA.

Materials and methods

PTW Diamond SCS is capable of calculating VMAT fields, based on modified Clarkson integration, accounting for multi-leaf collimators (MLC) transmission and measured collimator scatter factors. Validation for heterogeneity corrections is made using circular phantom with inserts of various density materials. 150 VMAT plans were compared using (i) plans calculated in homogeneous cylindrical phantom and (ii) VMAT plans calculated with heterogeneity corrections using electron density values for each organ.

Results

Diamond SCS calculated dose for homogeneous cylindrical phantom resulted in average deviation of (0.1[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]2.14%) with Eclipse TPS calculated dose and (−2.0[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]1.66%) with absolute measured dose. PTW's OCTAVIUS-4D phantom with 729 ion chamber detector array measurements agreed well with Eclipse TPS calculated dose showing an average deviation of (−1.69[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]1.56%). Diamond SCS dose calculations were performed with heterogeneity corrections for 124 VMAT plans with isocentre at a region above −350[[ce:hsp sp="0.25"/]]HU. The overall MU variations between Diamond SCS and TPS Acuros-XB algorithms were within ±5%.

Conclusion

Hence, the Diamond SCS can be used as an additional tool along with phantom measurements for patient specific quality assurance of VMAT plans with heterogeneity corrections having isocentre at a region above −350[[ce:hsp sp="0.25"/]]HU.

Abstract

Aim

To validate and implement PTW diamond secondary check software (SCS) in a routine clinical use.

Background

The secondary independent monitor unit or dose calculation verifications have led to a significant increase in the workflow associated with QA treatments. Modelling, validation and commissioning are necessary steps thereby making it a useful tool for QA.

Materials and methods

PTW Diamond SCS is capable of calculating VMAT fields, based on modified Clarkson integration, accounting for multi-leaf collimators (MLC) transmission and measured collimator scatter factors. Validation for heterogeneity corrections is made using circular phantom with inserts of various density materials. 150 VMAT plans were compared using (i) plans calculated in homogeneous cylindrical phantom and (ii) VMAT plans calculated with heterogeneity corrections using electron density values for each organ.

Results

Diamond SCS calculated dose for homogeneous cylindrical phantom resulted in average deviation of (0.1[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]2.14%) with Eclipse TPS calculated dose and (−2.0[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]1.66%) with absolute measured dose. PTW's OCTAVIUS-4D phantom with 729 ion chamber detector array measurements agreed well with Eclipse TPS calculated dose showing an average deviation of (−1.69[[ce:hsp sp="0.25"/]]±[[ce:hsp sp="0.25"/]]1.56%). Diamond SCS dose calculations were performed with heterogeneity corrections for 124 VMAT plans with isocentre at a region above −350[[ce:hsp sp="0.25"/]]HU. The overall MU variations between Diamond SCS and TPS Acuros-XB algorithms were within ±5%.

Conclusion

Hence, the Diamond SCS can be used as an additional tool along with phantom measurements for patient specific quality assurance of VMAT plans with heterogeneity corrections having isocentre at a region above −350[[ce:hsp sp="0.25"/]]HU.

Get Citation

Keywords

Diamond SCS; VMAT; Heterogeneity corrections

About this article
Title

Validation and clinical implementation of commercial secondary check software with heterogeneity corrections

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 21, No 5 (2016)

Pages

473-479

Published online

2016-09-01

DOI

10.1016/j.rpor.2016.06.003

Bibliographic record

Rep Pract Oncol Radiother 2016;21(5):473-479.

Keywords

Diamond SCS
VMAT
Heterogeneity corrections

Authors

Vijayalakshmi Kuppusamy
Vivekanandan Nagarajan
Lavanya Murugan

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl